Allergy Testing

FeNO Testing

Fractional exhaled nitric oxide (FeNO) measures airway inflammation — guides asthma diagnosis and biologic therapy selection.

What This Test Evaluates

  • Eosinophilic airway inflammation
  • Asthma phenotype (eosinophilic vs. non-eosinophilic)
  • Response to inhaled corticosteroids
  • Biologic therapy eligibility
  • Adherence to controller medication

Who May Need This Test

  • Patients with suspected asthma
  • Patients with unclear asthma phenotype
  • Patients being evaluated for biologic therapy
  • Patients with poor response to ICS
  • Patients with suspected non-adherence

Preparation Requirements

  • Avoid eating for 1 hour before test
  • Avoid caffeine and alcohol before test
  • No smoking for at least 1 hour
  • Inform of all medications

Procedure

  • Breathe out steadily into FeNO analyzer
  • Measures nitric oxide concentration in exhaled breath
  • Results in parts per billion (ppb)
  • Takes ~5 minutes

Interpretation

  • Elevated FeNO (>50 ppb adults, >35 children) suggests eosinophilic inflammation
  • Supports asthma diagnosis and ICS responsiveness
  • Guides biologic therapy selection (anti-IL5 for high FeNO)
  • Declining FeNO suggests treatment response
  • Low FeNO suggests non-eosinophilic phenotype

Limitations

  • Elevated in non-asthma conditions (rhinitis, infection)
  • Affected by smoking, diet and medications
  • Cannot diagnose asthma alone
  • Does not identify specific triggers

Follow-Up

  • Guide biologic therapy selection
  • Monitor treatment response
  • Assess adherence
  • Adjust controller therapy

Related Pages

Ready to get answers?

Book a specialist consultation to discuss your symptoms and treatment options.

Medical disclaimer: This page is for educational purposes and does not constitute medical advice. Individual diagnosis and treatment require consultation with a qualified healthcare professional. If you are experiencing a medical emergency, seek immediate care.